Influence of Plasma Free Fatty Acids on Lipoprotein Synthesis and Diabetic Dyslipidemia

Abstract

The regulation of hepatic VLDL secretion mainly depends on apolipoprotein (apo) B synthesis, on microsomal triglyceride transfer protein, insulin and the availability of triglycerides, free fatty acids (FFA) and cholesteryl ester. Four sources of fatty acids are used for lipoprotein synthesis: de-novo lipogenesis, cytoplasmic triglyceride stores, fatty acids derived from lipoproteins taken up directly by the liver and plasma FFA. Quantitatively, de-novo lipogenesis plays a minor role in regulating VLDL synthesis, but evidently it is elevated under conditions of high carbohydrate feeding. Cytoplasmic triglyceride stores appear to essentially contribute to VLDL triglycerides. Plasma FFA enter the hepatocytes and are either oxidized or esterified. The relationship between oxidation and esterification appears to be important in regulating the VLDL synthesis. An enhanced esterification is accompanied by increased VLDL secretion. The addition of oleic acid to hepatocytes has been shown to stimulate production of VLDL triglyceride and apoB. In human beings, an acute experimental elevation of plasma FFA stimulates VLDL production. In healthy men strong positive relations were found between the late increases in large triglyceride-rich lipoproteins and plasma FFA concentrations after 6 h following a mixed meal. In contrast, n-3 fatty acids impair VLDL assembly and secretion.

Chronic hyperinsulinemia seems to stimulate VLDL production. On the other hand, the short-term addition of insulin has been shown to inhibit VLDL-triglyceride and apoB production in vitro. There is in vivo evidence that acute hyperinsulinemia suppresses VLDL-apoB and VLDL-triglyceride production in insulin-sensitive humans. Part of this action is due to suppression of plasma FFA. In patients with impaired glucose tolerance (IGT), VLDL production was increased when compared with subjects with normal glucose (NGT). When infusing a lipid emulsion, VLDL production could not be further stimulated in IGT patients in contrast to NGT persons. Hypertriglyceridemia in type 2 diabetes mellitus is usually the consequence of a VLDL overproduction. In type 2 diabetic patients, in contrast to normal men, insulin failed to suppress VLDL1 particle release. In normal men, an elevation of blood glucose led to a decrease in fatty acid oxidation and an increase in hepatic triglyceride secretion. Under these conditions, ∼ 30 % of total VLDL triglycerides coming out of the liver did not originate from plasma FFA. In conclusion, plasma FFA seem to play an important role in stimulating hepatic VLDL production. Other factors such as chronic hyperinsulinemia or nutrition modify this effect.

Free fatty acids - hepatic VLDL secretion - insulin - insulin resistance - diabetic dyslipidemia

References

• 1 Aarsland A, Wolfe R R. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men.  J Lipid Res. 1998;  39 1280-1286
• 2 Adeli K, Taghibiglou C, Van Iderstine S C, Lewis G F. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance.  Trends Cardiovasc Med. 2001;  11 170-176
• 3 Boquist S, Hamsten A, Karpe F, Ruotolo G. Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men.  Diabetologia. 2000;  43 185-193
• 4 Bordin P, Bodamer O A, Venkatesan S, Gray R M, Bannister P A, Halliday D. Effects of fish oil supplementation on apolipoprotein B100 production and lipoprotein metabolism in normolipidaemic males.  Eur J Clin Nutr. 1998;  52 104-109
• 5 Bremer J. The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects.  Prog Lipid Res. 2001;  40 231-268
• 6 Brown A M, Castle J, Hebbachi A M, Gibbons G F. Administration of n-3 fatty acids in the diets of rats or directly to hepatocyte cultures results in different effects on hepatocellular ApoB metabolism and secretion.  Arterioscler Thromb Vasc Biol. 1999;  19 106-114
• 7 Cummings M H, Watts G F, Umpleby A M, Hennessy T R, Naoumova R, Slavin B M, Thompson G R, Sönksen P H. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.  Diabetologia. 1995;  38 959-967
• 8 Dashti N, Feng Q, Franklin F A. Long-term effects of cis and trans monounsaturated (18: 1) and saturated (16: 0) fatty acids on the synthesis and secretion of apolipoprotein A-I- and apolipoprotein B-containing lipoproteins in HepG2 cells.  J Lipid Res. 2000;  41 1980-1990
• 9 Goldberg I J. Clinical review 124: Diabetic dyslipidemia: causes and consequences.  J Clin Endocrinol Metab. 2001;  86 965-971
• 10 Hellerstein M K, Christiansen M, Kaempfer S, Kletke C, Wu K, Reid J S, Mulligan K, Hellerstein N S, Shackleton C H. Measurement of de novo hepatic lipogenesis in humans using stable isotopes.  J Clin Invest. 1991;  87 1841-1852
• 11 Julius U, Leonhardt W, Schulze J, Schollberg K, Haller H. Insulin resistance in diabetics and non-diabetics with impaired triglyceride removal.  Exp Clin Endocrinol. 1984;  83 225-230
• 12 Lang C A, Davis R A. Fish oil fatty acids impair VLDL assembly and/or secretion by cultured rat hepatocytes.  J Lipid Res. 1990;  31 2079-2086
• 13 Laws A. Free fatty acids, insulin resistance and lipoprotein metabolism.  Curr Opin Lipidol. 1996;  7 172-177
• 14 Lewis G F. Fatty acid regulation of very low density lipoprotein production.  Curr Opin Lipidol. 1997;  8 146-153
• 15 Lewis G F, Uffelman K D, Szeto L W, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals.  Diabetes. 1993;  42 833-842
• 16 Lewis G F, Zinman B, Uffelman K D, Szeto L, Weller B, Steiner G. VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin.  Am J Physiol. 1994;  267 E566-572
• 17 Lewis G F, Uffelman K D, Szeto L W, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.  J Clin Invest. 1995;  95 158-166
• 18 Lin Y, Schuurbiers E, Van der Veen S, De Deckere E A. Conjugated linoleic acid isomers have differential effects on triglyceride secretion in Hep G2 cells.  Biochim Biophys Acta. 2001;  1533 38-46
• 19 Malmstrom R, Packard C J, Caslake M, Bedford D, Stewart P, Yki-Jarvinen H, Shepherd J, Taskinen M R. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.  Diabetologia. 1997;  40 454-462
• 20 Malmstrom R, Packard C J, Caslake M, Bedford D, Stewart P, Shepherd J, Taskinen M R. Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.  Atherosclerosis. 1999;  146 381-390
• 21 Mittendorfer B, Sidossis L S. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets.  Am J Clin Nutr. 2001;  73 892-899
• 22 Mostaza J M, Vega G L, Snell P, Grundy S M. Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue.  J Intern Med. 1998;  243 265-274
• 23 Parks E J, Krauss R M, Christiansen M P, Neese R A, Hellerstein M K. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance.  J Clin Invest. 1999;  104 1087-1096
• 24 Pietzsch J, Julius U, Kirch C, Fischer S, Hanefeld M. Very low density lipoprotein overproduction is maximally expressed in early insulin resistant states.  Ann NY Acad Sci. 1999;  892 319-322
• 25 Sidossis L S, Mittendorfer B, Walser E, Chinkes D, Wolfe R R. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion.  Am J Physiol. 1998;  275 E798-805
• 26 Sniderman A D, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus.  Ann Intern Med. 2001;  135 447-459
• 27 Steiner G, Lewis G F. Hyperinsulinemia and triglyceride-rich lipoproteins.  Diabetes. 1996;  45 (Suppl 3) S24-S26
• 28 Taskinen M R. Pathogenesis of dyslipidemia in type 2 diabetes.  Exp Clin Endocrinol Diabetes. 2001;  109 (Suppl 2) S180-S188
• 29 Wiggins D, Gibbons G F. Origin of hepatic very-low-density lipoprotein triacylglycerol: the contribution of cellular phospholipid.  Biochem J. 1996;  320 673-679
• 30 Zheng X, Avella M, Botham K M. Comparison of the effects of dietary n-3 and n-6 polyunsaturated fatty acids on very-low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants.  Biochem J. 2001;  357 481-487